Geoff Mcdonough - 02 Feb 2026 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
Director
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
Issuer symbol
GBIO
Transactions as of
02 Feb 2026
Net transactions value
-$3,102
Form type
4
Filing time
04 Feb 2026, 16:05:27 UTC
Previous filing
16 Jan 2026
Next filing
09 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCDONOUGH GEOFF Director C/O GENERATION BIO CO., 301 BINNEY ST, CAMBRIDGE /s/ Shawna-Gay White, Attorney-in-Fact 04 Feb 2026 0001732701

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBIO Common Stock Options Exercise +1,582 +1.2% 139,042 02 Feb 2026 Direct F1
transaction GBIO Common Stock Tax liability $3,102 -550 -0.4% $5.64 138,492 02 Feb 2026 Direct
holding GBIO Common Stock 22,646 02 Feb 2026 By 2018 Trust F2
holding GBIO Common Stock 27,500 02 Feb 2026 By 2020 Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Restricted Stock Units Options Exercise $0 -1,582 -100% $0.000000 0 02 Feb 2026 Common Stock 1,582 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the company's common stock.
F2 The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the 2018 Trust. The reporting person is the settlor of the 2018 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2018 Trust, and the 2018 Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2018 Trust.
F3 The securities are directly held by the McDonough Family 2020 Irrevocable Trust, or the 2020 Trust. The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust, and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust.
F4 On January 20, 2023, the reporting person was granted 8,437 restricted stock units. Pursuant to the terms of that certain Agreement and Plan of Merger, by and among the Issuer, XOMA Royalty Corporation ("Parent") and Parent's wholly-owned subsidiary, XRA 7 Corp., dated as of December 15, 2025 (the "Merger Agreement"), prior to the effective time of the merger as contemplated by the Merger Agreement, each restricted stock unit of the Issuer that was outstanding and unvested became vested in full on February 2, 2026.